摘要

<正>Cancer is recognized as a leading cause of deaths nowadays,accounting for 10 million annual deaths worldwide and resulting in heavy health and economic burdens [1]. Reducing cancer incidence through precision prevention is thus of great scientific and clinical value. Gastric cancer(GC) is one of the most common cancers in China. Pathologically, the onset of GC, especially the intestinal-type ones, would usually suffer a series of premalignant lesions, including atrophic gastritis, intestinal metaplasia,